Peralta-BuendÃa, K.; Cuevas-López, B.; GarcÃa-Arroyo, F.E.; DÃaz-Rojas, M.; León-Contreras, J.C.; Silva-Palacios, A.; Gonzaga, G.; Tapia, E.; Saavedra, E.; Hernández-Pando, R.;
et al. Early Administration of N-Acetylcysteine Provides Renal and Cardiac Mitochondrial and Redox Protection, Preventing the Development of Cardio-Renal Syndrome Type IV Induced by 5/6NX. Antioxidants 2025, 14, 1241.
https://doi.org/10.3390/antiox14101241
AMA Style
Peralta-BuendÃa K, Cuevas-López B, GarcÃa-Arroyo FE, DÃaz-Rojas M, León-Contreras JC, Silva-Palacios A, Gonzaga G, Tapia E, Saavedra E, Hernández-Pando R,
et al. Early Administration of N-Acetylcysteine Provides Renal and Cardiac Mitochondrial and Redox Protection, Preventing the Development of Cardio-Renal Syndrome Type IV Induced by 5/6NX. Antioxidants. 2025; 14(10):1241.
https://doi.org/10.3390/antiox14101241
Chicago/Turabian Style
Peralta-BuendÃa, Karen, Belén Cuevas-López, Fernando E. GarcÃa-Arroyo, Miriam DÃaz-Rojas, Juan Carlos León-Contreras, Alejandro Silva-Palacios, Guillermo Gonzaga, Edilia Tapia, Emma Saavedra, Rogelio Hernández-Pando,
and et al. 2025. "Early Administration of N-Acetylcysteine Provides Renal and Cardiac Mitochondrial and Redox Protection, Preventing the Development of Cardio-Renal Syndrome Type IV Induced by 5/6NX" Antioxidants 14, no. 10: 1241.
https://doi.org/10.3390/antiox14101241
APA Style
Peralta-BuendÃa, K., Cuevas-López, B., GarcÃa-Arroyo, F. E., DÃaz-Rojas, M., León-Contreras, J. C., Silva-Palacios, A., Gonzaga, G., Tapia, E., Saavedra, E., Hernández-Pando, R., Pedraza-Chaverri, J., Sánchez-Lozada, L. G., & Aparicio-Trejo, O. E.
(2025). Early Administration of N-Acetylcysteine Provides Renal and Cardiac Mitochondrial and Redox Protection, Preventing the Development of Cardio-Renal Syndrome Type IV Induced by 5/6NX. Antioxidants, 14(10), 1241.
https://doi.org/10.3390/antiox14101241
